Toresson G, Brodin E, Bertilsson L
Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Regul Pept. 1993 Jul 2;46(1-2):357-9. doi: 10.1016/0167-0115(93)90085-m.
With HPLC-RIA methods we were unable to demonstrate SP and NKA in measurable amounts in human CSF. Instead N-terminally extended forms of these peptides were found to be present and could be quantitated. The finding that these forms of tachykinins can be released from nervous tissue might suggest that their levels in CSF can be used as markers of the activity in central SP and NKA neurons.
采用高效液相色谱 - 放射免疫分析方法,我们未能在人脑脊液中检测到可测量量的速激肽(SP)和神经激肽A(NKA)。相反,发现这些肽的N端延伸形式存在且可进行定量分析。这些速激肽形式可从神经组织释放这一发现可能表明,它们在脑脊液中的水平可作为中枢SP和NKA神经元活性的标志物。